Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes

被引:3
|
作者
Cho, Yoosun [1 ]
Chang, Yoosoo [2 ,3 ,4 ]
Ryu, Seungho [2 ,3 ,4 ]
Wild, Sarah H. [5 ]
Byrne, Christopher D. [6 ,7 ]
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Total Healthcare Ctr, Sch Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Ctr Cohort Studies, Sch Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Sch Med, Samsung Main Bldg B2,250 Taepyung Ro 2ga, Seoul 04514, South Korea
[4] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul, South Korea
[5] Univ Edinburgh, Usher Inst, Edinburgh, Scotland
[6] Univ Southampton, Fac Med, Nutr & Metab, Southampton, England
[7] Univ Hosp Southampton, Natl Inst Hlth & Care Res Southampton Biomed Res C, Southampton, England
基金
新加坡国家研究基金会;
关键词
Non-alcoholic fatty liver disease; Gestational diabetes mellitus; Type 2 diabetes mellitus; Cohort study; ASSESSMENT SCORE; HISPANIC WOMEN; MELLITUS; VALIDATION; PREDICTION; ASSOCIATION; SENSITIVITY; DIAGNOSIS; PEOPLE; SCREEN;
D O I
10.1007/s10654-023-01016-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Whether non-alcoholic fatty liver disease (NAFLD) improves risk prediction for subsequent type 2 diabetes mellitus (T2DM) in women with prior gestational diabetes mellitus (pGDM) is uncertain. We examined the combined effects of NAFLD and pGDM on risk prediction for incident T2DM. This retrospective cohort study included 97,347 Korean parous women without diabetes mellitus at baseline whose mean (SD) age was 39.0 (7.8) years. Cox proportional hazards models were used to estimate hazard ratios (HRs) for incident T2DM according to self-reported pGDM and ultrasound-diagnosed NAFLD at baseline. When combined with conventional diabetes risk factors, the incremental predictive ability of NAFLD and pGDM to identify incident T2DM was assessed. During a median follow-up of 3.9 years, 1,515 cases of incident T2DM occurred. Multivariable-adjusted HRs (95% confidence intervals [CIs]) for incident T2DM comparing pGDM alone, NAFLD alone, and both NAFLD and pGDM to the reference (neither NAFLD nor pGDM) were 2.61 (2.06-3.31), 2.26 (1.96-2.59), and 6.45 (5.19-8.00), respectively (relative excess risk of interaction = 2.58 [95% CI, 1.21-3.95]). These associations were maintained after adjusting for insulin resistance, body mass index, and other potential confounders as time-dependent covariates. The combination of NAFLD and pGDM improved risk prediction for incident T2DM (based on Harrell's C-index, also known as the concordance index, and net reclassification improvement) compared to conventional diabetes risk factors. In conclusion, NAFLD synergistically increases the risk of subsequent T2DM in women with pGDM. The combination of NAFLD and pGDM improves risk prediction for T2DM.
引用
收藏
页码:901 / 911
页数:11
相关论文
共 50 条
  • [21] Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
    Mantovani, Alessandro
    Dalbeni, Andrea
    Beatrice, Giorgia
    Cappelli, Davide
    Gomez-Peralta, Fernando
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [22] Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes
    Aller de la Fuente, Rocio
    Mora Cuadrado, Natalia
    Tafur, Carla
    Lopez Gomez, Juan Jose
    Gomez de la Cuesta, Sara
    Garcia Sanchez, Maria Concepcion
    Antolin Melero, Beatriz
    de Luis Roman, Daniel Antonio
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (06): : 354 - 360
  • [23] Association Between the Risk of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease
    Zhao, Pingping
    Yan, Junxin
    Pan, Binjing
    Liu, Jingfang
    Fu, Songbo
    Cheng, Jianguo
    Wang, Liting
    Jing, Gaojing
    Li, Qiong
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 1141 - 1151
  • [24] Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China
    Yi, M.
    Chen, R. -P.
    Yang, R.
    Chen, H.
    DIABETIC MEDICINE, 2017, 34 (04) : 505 - 513
  • [25] High-Normal Serum Thyrotropin Levels Increased the Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects with Type 2 Diabetes
    Tan, Ying
    Tang, Xixiang
    Mu, Panwei
    Yang, Yi
    Li, Mei
    Nie, Yuanpeng
    Li, Haicheng
    Zhu, Yanhua
    Chen, Yanming
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 2841 - 2849
  • [26] Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes
    Nobarani, Sohrab
    Alaei-Shahmiri, Fariba
    Aghili, Rokhsareh
    Malek, Mojtaba
    Poustchi, Hossein
    Lahouti, Maryam
    Khamseh, Mohammad E.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (04) : 1389 - 1398
  • [27] Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?
    Targher, G.
    Marchesini, G.
    Byrne, C. D.
    DIABETES & METABOLISM, 2016, 42 (03) : 142 - 156
  • [28] Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease
    Tada, Toshifumi
    Toyoda, Hidenori
    Sone, Yasuhiro
    Yasuda, Satoshi
    Miyake, Nozomi
    Kumada, Takashi
    Tanaka, Junko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (11) : 2011 - 2018
  • [29] Predictors of Non-Alcoholic Fatty Liver Disease in Diabetes
    Hosseinpanah, F.
    Rambod, M.
    Sadeghi, L.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2007, 5 (02) : 61 - 69
  • [30] Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease
    Shi, Mengran
    Zhang, Hao
    Wang, Wei
    Zhang, Xiao
    Liu, Jiawei
    Wang, Qixian
    Wang, Yuan
    Zhang, Chunlin
    Guo, Xiaoqin
    Qiao, Qiao
    Cui, Chun
    Xu, Jing
    Wang, Jian
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (10)